Navigation Links
InspireMD Reports Financial Results For Period Ended March 31, 2013
Date:5/8/2013

board of directors in February. Since leaving Boston Scientific, he co-founded or was a founding director of seven medical technology companies, three of which sold for more than $350 million, plus $100 million in contingent payments.

--The Company received CE Mark approval for its self-expanding Nitinol carotid EPS, further validating the MGuard MicroNet technology and strengthening its distributor and partnership strategy in the near term.

Recent Events--On April 16, the Company completed an underwritten public offering of 12.5 million common shares, raising net proceeds of approximately $22.6 million. A portion of the proceeds were used in connection with the retirement of the Company's outstanding debentures and the Company intends to use the balance of the proceeds to support the worldwide commercialization of the MGuard EPS, to pursue FDA approval in the U.S. of the MGuard EPS and for general corporate purposes. Concurrent with this funding, the Company's shares commenced trading on the NYSE MKT.

--On April 19, Gwen K. Bame joined the Company as Vice President of Corporate Development, a new position created to strengthen the Company's focus on executing strategic programs and partnerships designed to meet the Company's ambitious global growth objectives. Ms. Bame, who previously held executive positions with Boston Scientific and Covidien, is expected to identify and negotiate in/out licensing agreements, analyze strategic partnerships and structure joint ventures worldwide.

--On April 23, the Company announced it received approval with conditions from the FDA to commence a pivotal trial in support of its IDE application. An approval with conditions indicates the FDA concurs with the overall trial design and, while minor details are being finalized, it allows the Company to initiate enrollment in the randomized MASTER II IDE trial of patients suffering from ST Elevation Myocardial Infraction (STEMI). The principal investigators f
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
2. InspireMD Closes $25 Million Underwritten Public Offering
3. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
4. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
5. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
6. InspireMD Reports Results for Period Ended Dec. 31, 2012
7. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
8. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
9. InspireMD Reports Results For Period Ending Sept. 30, 2012
10. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
11. InspireMD to Present at Harvard Investors Group on June 27 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- E-QURE Corp (OTCQB: EQUR), today announced that Ron ... July 9, 2015. DATE: Thursday, July 9, 2015 ... This will be a live, interactive online event ... in real-time - both in the presentation hall as ... are not able to join the event live on ...
(Date:7/6/2015)... , July 6, 2015 Moerae ... developing novel therapeutics that target inflammation and fibrosis, ... , M.D., PhD, as Chief Medical Officer. ... clinical development strategy and programs, which include a ... inflammatory and fibrotic conditions.  Bill is an accomplished ...
(Date:7/6/2015)... July 6, 2015  Impax Laboratories, Inc. (NASDAQ: ... Ph.D. has resigned from the Company,s Board of Directors ... was a co-founder of Impax in 1995 and served ... October 2006 until April 2014. Logo - ... Impax,s President and Chief Executive Officer stated, "We wish ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5
... Osteotech, Inc. (Nasdaq: OSTE ), a leader ... healing, today reported financial results for the third quarter ... of 2009, our focus was on the release of ... FacetLinx(TM) Fusion Technology and Plexur M® Innovative Grafting," said ...
... Calif., Nov. 5 Renee Cobos, MD, a board ... University of California, Irvine, announced today that her patients ... system, which is approved for skin tightening and contouring, ... efficacy and improves patient comfort. , "Thermage has ...
Cached Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and ... Hospice received the Music & Memory Certification for hospice patients and adult day center ... music not only to patients but also to their families and volunteers. Music & ...
(Date:7/5/2015)... ... ... City Sports, the Boston-based specialty sporting goods retailer, has renewed their partnership ... this summer with ethos, the owner and operator of the Boston Triathlon. , The ... at the North End Greenway. The event will help new triathletes prepare for the ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in 2015, on ... an annual member survey , detailing the most common plastic surgery and minimally ... that raw data down into charts detailing demographic trends and regional preferences. With ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
Breaking Medicine News(10 mins):Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3
... of individuals who suffered from suicidal thoughts and erratic behavior ... ... Mineola, N.Y. (Lexis Nexis) August 5, 2008 - ... personal injury law firm Sanders Viener Grossman LLP, today announced ...
... TRAIT , A new study suggests that people who ... or phenotype that causes them to have poorer asthma ... Researchers from Quebec, Canada compared pulmonary function changes, methacholine ... circumference, and waist-to-hip ratio of 44 obese subjects with ...
... Medicare Regulation Protects, NC Seniors, Access to Quality ... Quality,Nursing Home Care today thanked North Carolina Senators Elizabeth ... bipartisan effort in,Congress to stop the Bush Administration from ... Medicare-funded nursing home care by $5,billion over the next ...
... 4, 2008 - A recent study published in ... (ESAs), a widely used drug to treat anemia, may ... patients. In the study, 323 multiple myeloma patients were ... 1988 to 2007. The investigators reviewed their medical records ...
... 4 Another Eniva nutraceutical moves,to the ... excellent quality and,valid claims. Eniva,s Efacor has ... standards from ConsumerLab.com. ConsumerLab.com,(CL) has long been ... and,quality among nutritional products. CL,s stringent testing ...
... - Total revenue increased 11 percent ... management segment revenue represented 44 percent of total revenue, compared ... - Gross margin rose to 29.4 percent from 28 percent ... share repurchase plan, MINNEAPOLIS, Aug. 4 Health Fitness,Corporation (OTC Bulletin Board: HFIT), a ...
Cached Medicine News:Health News:New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs 2Health News:Chest Journal: August news briefs 2Health News:Dole, Burr Praised for Helping Lead Senate Effort to Stop $21.8 Million North Carolina Medicare Cuts 2Health News:Treatment with anti-anemia drugs may not be safe for multiple myeloma patients 2Health News:Eniva USA Efacor(R) Fish Oil (Non-Fishy Lemon Taste) Receives ConsumerLab.com Seal of Approval 2Health News:HealthFitness Announces 2008 Second Quarter Results 2Health News:HealthFitness Announces 2008 Second Quarter Results 3Health News:HealthFitness Announces 2008 Second Quarter Results 4Health News:HealthFitness Announces 2008 Second Quarter Results 5Health News:HealthFitness Announces 2008 Second Quarter Results 6Health News:HealthFitness Announces 2008 Second Quarter Results 7Health News:HealthFitness Announces 2008 Second Quarter Results 8Health News:HealthFitness Announces 2008 Second Quarter Results 9Health News:HealthFitness Announces 2008 Second Quarter Results 10
... The ADVIA 120 Hematology System gets ... right the first time, with a ... systems. Results are more accurate, physicians ... more effective. The ADVIA 120 Hematology ...
The Advia 60 is designed to deliver powerful performance in a small package....
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
... HmX offers three-dimensional VCS ... specificity and efficiency in ... reticulocyte analysis. With its ... dependability, HmX is an ...
Medicine Products: